YETI vs. RPRX
YETI (YETI Holdings, Inc.) and RPRX (Royalty Pharma plc) are both stocks. YETI operates in Leisure (Consumer Cyclical), while RPRX operates in Biotechnology (Healthcare). Over the past 5 years, YETI returned -12.84%/yr vs 6.05%/yr for RPRX. At a 0.26 correlation, their price movements are largely independent.
Performance
YETI vs. RPRX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, YETI achieves a 7.92% return, which is significantly lower than RPRX's 43.35% return.
YETI
- 1D
- 0.63%
- 1M
- 14.78%
- YTD
- 7.92%
- 6M
- 11.07%
- 1Y
- 51.00%
- 3Y*
- 9.92%
- 5Y*
- -12.84%
- 10Y*
- —
RPRX
- 1D
- -1.81%
- 1M
- 8.49%
- YTD
- 43.35%
- 6M
- 43.24%
- 1Y
- 65.89%
- 3Y*
- 21.75%
- 5Y*
- 6.05%
- 10Y*
- —
YETI vs. RPRX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
YETI YETI Holdings, Inc. | 7.92% | 14.70% | -25.63% | 25.34% | -50.13% | 20.97% | 84.56% |
RPRX Royalty Pharma plc | 43.35% | 55.29% | -6.36% | -27.08% | 0.99% | -19.09% | 13.33% |
Correlation
The correlation between YETI and RPRX is 0.25, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.25 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.21 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.29 |
Correlation (All Time) Calculated using the full available price history since Jun 17, 2020 | 0.26 |
Fundamentals
YETI:
$1.98
RPRX:
$1.97
YETI:
24.03
RPRX:
27.87
YETI:
2.68
RPRX:
0.03
YETI:
2.01
RPRX:
9.45
YETI:
$1.90B
RPRX:
$2.44B
YETI:
$1.08B
RPRX:
$1.81B
YETI:
$245.40M
RPRX:
$1.70B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
YETI vs. RPRX — Risk / Return Rank
YETI
RPRX
YETI vs. RPRX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for YETI Holdings, Inc. (YETI) and Royalty Pharma plc (RPRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| YETI | RPRX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.81 | ||
| Sortino ratioReturn per unit of downside risk | -1.95 | ||
| Omega ratioGain probability vs. loss probability | 1.22 | 1.50 | -0.28 |
| Calmar ratioReturn relative to maximum drawdown | 1.70 | 8.97 | -7.27 |
| Martin ratioReturn relative to average drawdown | 3.72 | 22.53 | -18.81 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| YETI | RPRX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.22 | 3.03 | -1.81 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.27 | 0.25 | -0.52 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.27 | 0.22 | +0.05 |
Drawdowns
YETI vs. RPRX - Drawdown Comparison
The maximum YETI drawdown since its inception was -74.99%, which is greater than RPRX's maximum drawdown of -49.68%. Use the drawdown chart below to compare losses from any high point for YETI and RPRX.
Loading charts...
Drawdown Indicators
| YETI | RPRX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -74.99% | -49.68% | -25.31% |
Max Drawdown (1Y)Largest decline over 1 year | -30.08% | -7.38% | -22.70% |
Max Drawdown (3Y)Largest decline over 3 years | -49.74% | -22.84% | -26.90% |
Max Drawdown (5Y)Largest decline over 5 years | -74.99% | -43.44% | -31.55% |
Current DrawdownCurrent decline from peak | -55.75% | -1.81% | -53.94% |
Average DrawdownAverage peak-to-trough decline | -40.46% | -26.39% | -14.07% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.74% | 2.93% | +10.81% |
Volatility
YETI vs. RPRX - Volatility Comparison
YETI Holdings, Inc. (YETI) has a higher volatility of 12.84% compared to Royalty Pharma plc (RPRX) at 6.44%. This indicates that YETI's price experiences larger fluctuations and is considered to be riskier than RPRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| YETI | RPRX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.84% | 6.44% | +6.40% |
Volatility (6M)Calculated over the trailing 6-month period | 28.47% | 14.13% | +14.34% |
Volatility (1Y)Calculated over the trailing 1-year period | 42.03% | 21.92% | +20.11% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 48.49% | 23.86% | +24.63% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 53.20% | 26.86% | +26.34% |
Dividends
YETI vs. RPRX - Dividend Comparison
YETI has not paid dividends to shareholders, while RPRX's dividend yield for the trailing twelve months is around 1.66%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
RPRX Royalty Pharma plc | 1.66% | 2.28% | 3.29% | 2.85% | 1.92% | 1.71% | 0.60% |
YETI YETI Holdings, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
YETI vs. RPRX - Financials Comparison
This section allows you to compare key financial metrics between YETI Holdings, Inc. and Royalty Pharma plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
YETI vs. RPRX - Profitability Comparison
YETI - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, YETI Holdings, Inc. reported a gross profit of 210.21M and revenue of 380.41M. Therefore, the gross margin over that period was 55.3%.
RPRX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Royalty Pharma plc reported a gross profit of 0.00 and revenue of 631.00M. Therefore, the gross margin over that period was 0.0%.
YETI - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, YETI Holdings, Inc. reported an operating income of 12.44M and revenue of 380.41M, resulting in an operating margin of 3.3%.
RPRX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Royalty Pharma plc reported an operating income of 563.00M and revenue of 631.00M, resulting in an operating margin of 89.2%.
YETI - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, YETI Holdings, Inc. reported a net income of 9.85M and revenue of 380.41M, resulting in a net margin of 2.6%.
RPRX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Royalty Pharma plc reported a net income of 295.00M and revenue of 631.00M, resulting in a net margin of 46.8%.
Frequently Asked Questions
YETI and RPRX have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
YETI has higher volatility (12.84%) compared to RPRX (6.44%). In terms of maximum drawdown, YETI dropped -74.99% vs RPRX's -49.68%.
RPRX currently has the higher Sharpe Ratio (3.03 vs 1.22), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for YETI and RPRX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer